About
Nordic Nanovector AS is a Norwegian biotechnology company developing targeted therapies for hematological cancers by using monoclonal antibodies and antibody-radionuclide conjugates.
Explore Nordic Nanovector's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.